About Siteman Cancer Center
Siteman Cancer Center is one of only a few cancer centers to receive the highest rating of the National Cancer Institute (NCI) – “exceptional.” Comprising the cancer research, prevention and treatment programs of Barnes-Jewish Hospital and WashU Medicine in St. Louis, Siteman treats adults at six locations, including the new Gary C. Werths Building for outpatient care and an inpatient hospital on the Washington University Medical Campus, and partners with St. Louis Children’s Hospital in the treatment of pediatric patients at Siteman Kids. All locations offer patient-focused, multidisciplinary care driven by scientific breakthroughs and powered by WashU Medicine physicians.
Siteman is Missouri and southern Illinois’ only NCI-designated Comprehensive Cancer Center and only member of the National Comprehensive Cancer Network. Through the Siteman Cancer Network, Siteman Cancer Center works with regional health systems and hospitals to improve access to highly specialized cancer care and reduce the incidence of cancer through initiatives in cancer prevention, treatment and research.
QUICK FACTS:
- Established in 1999, Siteman is recognized as a leading cancer center by its peers and the NCI.
- Every year, 75,000 people are treated at Siteman, including 12,000 who are newly diagnosed.
- Siteman is powered by 600+ WashU Medicine physicians and scientists focused on the latest in cancer treatment and research.
- With 9,000+ patients enrolled in 700+ clinical studies, Siteman offers access to investigational therapies not generally available to the public.
- Siteman has held NCI’s highest rating – “exceptional” – since 2015, based on a rigorous review of its research programs.
- Siteman is also proud to receive more than $181 million annually for basic and clinical oncology research grants, including $65 million from the NCI, funding 1,400+ research projects. This includes three Specialized Programs of Research Excellence (SPORE) grants, for endometrial, leukemia and pancreatic research.
- In 2023, WashU faculty at Siteman filed for 196 patents.
- WashU Medicine has the second-largest research funding portfolio from the National Institutes of Health (NIH) among U.S. medical schools.